21 results
6-K
EX-10.1
ENLV
Enlivex Therapeutics Ltd
30 Dec 22
Report of Foreign Private Issuer
4:02pm
relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes
6-K
EX-1.1
h1tpo4 52
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
6-K
EX-10.1
37do3
22 Oct 20
Report of Foreign Private Issuer
8:47am
6-K
EX-1.1
9nyyrtrx
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-1.1
tdckmtl423zs 1kwknh
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
20-F/A
q5q3uz4bgp 34d
23 Jan 20
Annual report (foreign) (amended)
4:31pm
6-K
EX-99.2
h38man09wnylge2kf
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
6-K
EX-99.1
5r7fcwwkloo
19 Nov 18
Agreement and Plan of Merger
4:34pm
424B5
noyl0t9u1u83o6
18 Mar 16
Prospectus supplement for primary offering
12:00am
20-F
moaynb e5wj
31 Mar 15
Annual report (foreign)
12:00am
424B4
ds3ysrw
31 Jul 14
Prospectus supplement with pricing info
12:00am